Pablo L. Ortiz‐Romero
Universidad Complutense de Madrid(ES)Research Institute Hospital 12 de Octubre(ES)Universidad Regional del Sureste(MX)Hospital Universitario 12 De Octubre(ES)Pasqual Maragall Foundation(ES)University of Florence(IT)
Publications by Year
Research Areas
Cutaneous lymphoproliferative disorders research, Lymphoma Diagnosis and Treatment, T-cell and Retrovirus Studies, Fungal Infections and Studies, CAR-T cell therapy research
Most-Cited Works
- → Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases(2007)692 cited
- → Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study(2022)668 cited
- → Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer(2011)643 cited
- → Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial(2018)630 cited
- → Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial(2017)569 cited